Statistics for Xtant Medical Holdings (id:214 XTNT)
Valuation metrics
Market cap
51,22M
Enterprise value
99,98M
Trailing P/E (ttm)
75,11
Forward P/E
-12,28
PEG ratio
-12,28
Price/Sales (ttm)
3,00
Price/Book (mrq)
3,00
Enterprise Value/Revenue
3,00
Enterprise Value/EBITDA
-10,30
Overview
Shares outstanding
139,01M
Float
45,17M
Shares short
197,47K
% Held by insiders
5,00%
% Held by institutions
3,00%
Average volume (10 days)
288,12K
Average volume (90 days)
Price summary
52-Week low
3,00
52-Week high
1,30
52-Week change
-118,00%
Beta
3,00
50-Day moving average
3,00
200-Day moving average
3,00
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0,00%
Trailing annual dividend yield
0,00
5-Year annual dividend yield
Payout ratio
0,00
Dividend date
February 14, 2018
Ex-dividend date
Last split factor
2:1
Last split date
February 14, 2018
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
September 30, 2024
Profitability
Profit margin
-3,00%
Operating margin
-9,84%
Operational effectiveness
Return on assets
-10,58%
Return on equity
-8,77%
Income statement
Revenue (ttm)
3,00
Revenue per share (ttm)
3,00
Quarterly revenue growth (yoy)
3,00
Gross profit (ttm)
55,47M
EBITDA
-9.704.000,00
Net income to common (ttm)
-3.333.000,00
Diluted EPS (ttm)
3,00
Quarterly earnings growth (yoy)
11,66%
Balance sheet
Total cash (mrq)
5,38M
Total cash per share (mrq)
5,00
Total debt (mrq)
34,99M
Total Debt/Equity (mrq)
77,74
Current ratio (mrq)
243,60%
Book value per share (mrq)
3,00
Cash flow
Cash flow statement
-15.592.000,00
Levered free cash flow (LFCF)
-28.139.500,00